Status:
COMPLETED
Immunomodulating Effects of Supplementation With 25-OH Vitamin D
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Conditions:
Vitamin D Deficiency
Scleroderma, Systemic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Introduction. The thickening fibrotic of the skin in systemic sclerosis (SSc) could reduce endogenous availability of Vitamin D by sun exposition. Vitamin D hypovitaminosis have been described in high...
Detailed Description
The study will be carried out with prior authorization from the Local Research and Ethics Committee. Patients entitled to our healthcare services and complying with screening criteria will be included...
Eligibility Criteria
Inclusion
- Scleroderma individuals according to 2013 American College of Rheumatology/European League against Rheumatism (ACR/EULAR 2013) classification criteria for SSc.
Exclusion
- insufficient data to enable classification
- any acute bacterial infection
- abnormal kidney function
- comorbidity
- other chronic disease degenerative disease such as diabetes and malignancies
- subjects who received biological therapy or mycophenolate-mofetil during the previous month.
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT04822038
Start Date
June 1 2017
End Date
December 31 2019
Last Update
April 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Méxicano del Seguro Social
Mexico City, Mexico, 02990